Cart
sales@molnova.com
Celosin K
CAS No. 1950579-53-9
Celosin K( ——— )
Catalog No. M39043 CAS No. 1950579-53-9
Celosin K (compound 8) can be isolated from the seeds of Semen Celosiae. Celosin K is a potent inhibitor of neuron injury elicited by t-BHP. Celosin K inhibits oxidative stressand apoptosis, and acts of autophagy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 1270 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameCelosin K
-
NoteResearch use only, not for human use.
-
Brief DescriptionCelosin K (compound 8) can be isolated from the seeds of Semen Celosiae. Celosin K is a potent inhibitor of neuron injury elicited by t-BHP. Celosin K inhibits oxidative stressand apoptosis, and acts of autophagy.
-
DescriptionCelosin K (compound 8) can be isolated from the seeds of Semen Celosiae. Celosin K is a potent inhibitor of neuron injury elicited by t-BHP. Celosin K inhibits oxidative stressand apoptosis, and acts of autophagy.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1950579-53-9
-
Formula Weight943.08
-
Molecular FormulaC47H74O19
-
Purity>98% (HPLC)
-
SolubilityH2O : 9.4308 mg/mL (10.00 mM; ultraphonic)
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jinggong Guo, et al. Chemical compounds with a neuroprotective effect from the seeds of Celosia argentea L. Food Funct. 2021, 12, 83-96.
molnova catalog
related products
-
Bletilol B
Bletilol B is a natural product for research related to life sciences.
-
PF-DcpSi
A potent inhibitor of the mRNA decapping scavenger enzyme (DcpS) with IC50 of 0.11 nM; shows no significant activity for DHFR (IC50>30 uM).
-
Oroxylin A
Oroxylin A possesses abilities of inhibiting the ATRA-induced IL-6 production via modulation of LAP/LIP/CHOP in leukemia cell lines, which could providing a therapeutic strategy for RAS.
